SARS-CoV-2 S1 (RBD) Mu B.1.621 (Columbia), GFP/His-Tag

€420.00 €470.00

Price excl. shipping costs excl. VAT. For more information, see our shipping policy

SKU: P2020-057_100 trenzyme

Contact us for a quote

Need a quote for an individual request or for a bulk order?

Please contact us.

Description

Recombinant protein of the receptor binding domain (RBD), Mutant (R346K, E484K, N501Y) of SARS-CoV-2 (COVID-2019) spike S1 from Wuhan pneumonia virus with C-terminal GFP/His tag. The mutations R346K, E484K, and N501Y are identified in the SARS-CoV-2 virus variant B.1.621, which emerged in South America and was first reported in Colombia in January 2021. B.1.621 classified as Variant of Interest (VOI) and also known as Mu variant. The mutations are located in the RBD domain of SARS-CoV-2 and bind with high affinity to the human ACE2 receptor. The Colombian Mu variant initiates infection in the upper respiratory tract and is considered as the fastest spreading variant and one of the most dangerous.

trenzyme cellebrity kolben

Get in contact with us


By submitting this form, I consent to trenzyme GmbH receiving and processing my data in order to process my inquiry. My consent is voluntary and I may revoke this consent at any time without providing any reasons, e.g. by sending an email to privacy(at)trenzyme.com with effect for the future. Further notices on data processing can be found in our privacy policy.